Neuble AI

What Neuble AI does

Neuble AI is an innovative medical AI solution company that integrates artificial intelligence technology with CT imaging to provide precise brain information at an MRI level. The company aims to overcome the limitations of existing medical imaging systems and set new standards for human health. Neuble AI focuses on discovering hidden value in data to provide quick diagnoses for patients and accurate judgment criteria for medical professionals. Their vision is to break down medical barriers by offering MRI-level precision from easily accessible CT scans, thereby improving medical equity and reducing regional healthcare disparities. They are expanding their product line to become an all-in-one platform for brain disease diagnosis.

Products

• BrainCuraBrainCura is the world's first and only CT-based brain segmentation technology that provides information necessary for diagnosing various brain diseases. It uses a unique AI algorithm to segment 98 micro-regions of the brain and measure their volume from CT images. It offers high-precision volumetric analysis results consistent with MRI volumetry, significantly shortening the cumbersome and time-consuming MRI-based analysis process. It also demonstrates robustness to metal artifacts, allowing for accurate tracking of core structures even in noisy images, making it applicable to elderly and surgical patients.
• AngioCuraFuture product for brain vascular analysis.
• ReadCuraFuture product for image reading assistance.

Key capabilities

• CT-based brain segmentation
• MRI-level precision from CT images
• Automated image segmentation and analysis
• PACS integration for result transmission
• High consistency with MRI volumetry
• Robustness to metal artifacts
• Lobar analysis (8 brain regions)
• Brain Health Score (objective health indicator)
• Core Structure Deep Dive (analysis of subcortical structures)
• Full Brain Health Mapping (98 detailed regions)
• Automated generation of key reports for neurodegenerative diseases (brain atrophy patterns, CT-based brain age, Alzheimer's progression monitoring)
• Segmentation performance (DSC) of 0.92 for major brain structures

Use cases

• Precise diagnosis of brain diseases
• Providing information for various disease diagnoses
• Shortening MRI-based analysis processes
• Improving operational efficiency in medical institutions
• Managing brain health based on data
• Predicting and preparing for potential brain diseases at an early stage
• Diagnosis and tracking of neurodegenerative brain diseases (e.g., Alzheimer's, Parkinson's)
• Monitoring Alzheimer's progression

AI approach

Neuble AI develops AI algorithms to analyze CT images for brain disease diagnosis. Their core product, BrainCura, uses AI to segment 98 micro-regions of the brain from CT scans and measure their volume, providing MRI-level precision. They claim to have developed the world's first and only CT-based brain microstructure segmentation technology. The AI also generates reports for clinical value such as brain atrophy pattern analysis, CT-based brain age calculation, and Alzheimer's progression monitoring.

Tech named: AI algorithms, deep learning

Industries served

• Healthcare

What it says sets it apart

• World's first and only CT-based brain microstructure segmentation technology
• Possesses the only technology capable of analyzing both CT and MR images
• Achieves 0.92 Dice similarity coefficient for image segmentation accuracy (world's highest for CT)
• Provides high-precision volumetric analysis results consistent with MRI volumetry
• Industry-leading segmentation precision in patients with metal artifacts
• Offers a Brain Health Score based on AI learning from thousands of brain CT datasets
• Core Structure Deep Dive for tracking subtle changes in subcortical structures
• Full Brain Health Mapping with 98 detailed regions for comprehensive analysis
• Overcomes limitations of MRI (long waiting times, high costs, restrictions for claustrophobia/metal implants)
• Proven technology with patent applications and developed using large-scale multi-institutional data
• Co-founded by current university hospital professors and medical AI experts with over 15 years of clinical experience and advanced imaging/AI technology capabilities
• Offers both On-Premise and SaaS business models to maximize scalability and accessibility

Funding rounds we track

From the AI funding tracker — rounds as reported by the linked publications.